AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Laser Treatment for Skin Longevity and Non-Melanoma Skin Cancer Prevention

Description

The talk describes how laser and energy-based skin treatments, originally explored to treat basal cell carcinoma non-invasively, may also help prevent future non-melanoma skin cancers and promote skin longevity. Using selective photothermolysis, investigators targeted the abnormal vasculature of basal cell cancers with pulsed dye laser (PDL) and 1064 nm Nd:YAG, achieving about 90% clearance in several studies with minimal or no scarring and little downtime. Nd:YAG alone showed strong results in a larger study, and OCT and histology supported vascular-specific injury. The speaker then reviewed prevention studies showing that ablative resurfacing, ablative fractional resurfacing, and non-ablative fractional resurfacing were associated with fewer actinic keratoses and fewer subsequent keratinocyte cancers over years of follow-up. Mechanistically, the benefits may involve wound-healing responses, increased immune surveillance, reduced inflammation, removal of senescent fibroblasts, and restoration of IGF-1 and normal UVB responses, which may improve DNA repair and lower cancer susceptibility. A retrospective study also found that PDL-treated patients had roughly half the rate of later facial keratinocyte cancers compared with matched controls, suggesting a possible protective role, though prospective studies are still needed.

View more

Conclusions

  • Laser-based treatments can selectively target the abnormal vasculature of basal cell carcinoma and achieve meaningful clearance while avoiding scars and wound care.
  • Long-pulsed 1064 nm Nd:YAG laser treatment appears more effective than superficial pulsed dye laser alone for some basal cell carcinomas because it reaches deeper tumor vessels.
  • Anticoagulation may reduce the efficacy of vascular-targeted laser treatment by limiting the coagulative vascular destruction needed for tumor regression.
  • In retrospective and pilot studies, pulsed dye laser treatment showed about a 50% reduction in subsequent facial keratinocyte cancer development in previously affected patients.
  • Ablative resurfacing and chemical peel approaches can lower actinic keratoses and may reduce future non-melanoma skin cancer incidence over years of follow-up.
  • Ablative fractional resurfacing produced a strong preventive signal, with far fewer non-melanoma skin cancers in treated skin than untreated skin over three years.
  • Non-ablative fractional resurfacing also appears to reduce later keratinocyte cancers and may halve the risk of subsequent facial disease in high-risk patients.
  • Fractional laser resurfacing may promote skin longevity by increasing IGF-1 signaling, improving DNA repair, and reducing the biologic effects of photoaged, senescent skin.
  • Recent data suggest that fractional laser treatment can decrease senescent fibroblasts and shift skin toward a more youthful, regenerative state.
  • Overall, the presentation argues that certain lasers are not only cosmetic tools but may be safe, well-tolerated, and practical therapies for both skin cancer prevention and skin rejuvenation.
  • N. Konnikov, M.M. Avram, A. Jarell, and Z.S. Tannous. Lasers Surg Med. 2011; 43(2):72–78.
  • Jalian HR, Avram MM, Stankiewicz KJ, Shofner JD, Tannous Z. Combined 585 nm pulsed-dye and 1,064 nm Nd:YAG lasers for the treatment of basal cell carcinoma. Lasers Surg Med. Jan 2014; 46(1):1-7.
  • AE Ortiz, RR Anderson, MM Avram. 1064 nm long-pulsed Nd:YAG laser treatment of basal cell carcinoma. 2015; 47(2): 106-110.
  • A Ortiz, RR Anderson, CM DiGiorgio, Faiza Shafiq, B Jiang. An expanded study of long-pulsed 1064nm Nd:YAG laser treatment of Basal Cell Carcinoma. Laser Surg Med 2018.#10.1002/lsm.22803
  • J Ahluwalia, MM Avram, AE Oritz. Outcomes of long-pulsed 1064 nm Nd:YAG laser treatment of basal cell carcinoma: A retrospective review. Lasers Surg Med 2019; 51(1) 34-39.#10.1002/lsm.23041
  • Arch Dermatol. 2006;142(8):976-982.
  • J Clin Invest. 2021 Oct 1; 131(19): e150972.
  • Dermatol Surg. 2023 Feb 1;49(2):149-154.
  • Frommeyer TC, Rohan CA, Spandau DF, Kemp MG, Wanner MA, Tanzi E and Travers JB. Wounding Therapies for Prevention of Photocarcinogenesis. Frontiers in Oncology. 2022; Jan.#10.3389/fonc.2021.813132
  • Kemp MG, Spandau DF and Travers JB. Molecules 2017; 22:356.
  • Gye J et al., Dermatol Surg 2015; 41:378-386.
  • Hibler, Kagha, Wilson, Vazirnia, Travers, Spandau, Tanzi, Lima, Alora, and Wanner. ASDS 2023.
  • JAMA Dermatology 2015.
  • British Journal of Cancer 2015.